ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 173 filers reported holding ANI PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $168,000 | +4.3% | 2,900 | +16.0% | 0.04% | +10.8% |
| Q4 2017 | $161,000 | +22.9% | 2,500 | 0.0% | 0.04% | +27.6% |
| Q3 2017 | $131,000 | +47.2% | 2,500 | +31.6% | 0.03% | +123.1% |
| Q2 2017 | $89,000 | -28.2% | 1,900 | -24.4% | 0.01% | -7.1% |
| Q1 2017 | $124,000 | +44.2% | 2,514 | +93.4% | 0.01% | +27.3% |
| Q3 2016 | $86,000 | -70.7% | 1,300 | -72.3% | 0.01% | -79.2% |
| Q1 2015 | $294,000 | – | 4,700 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
| Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
| Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
| Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
| 1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
| THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
| Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
| Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |